Transition Therapeutics Inc.
415 Yonge Street
Suite 1103
Toronto
Ontario
M5B2E7
Canada
Tel: 416-260-7770
Fax: 416-260-2886
183 articles about Transition Therapeutics Inc.
-
Transition Therapeutics Inc. Announces Results From ELND005 Clinical Study In Adults With Down Syndrome
11/20/2014
-
Transition Therapeutics Inc. Announces First Quarter Fiscal 2015 Financial Results
11/13/2014
-
Transition Therapeutics Inc. To Hold Conference Call On First Quarter Fiscal 2015 Financial Results On Wednesday, November 12th, At 4:30 P.M. EST
11/10/2014
-
Transition Therapeutics Inc. Reports Findings From Bipolar Disorder Phase 2 Study
11/4/2014
-
Transition Therapeutics Inc. Announces Fiscal 2014 Year End Financial Results
9/26/2014
-
Transition Therapeutics Inc. To Hold Conference Call On Full Year Fiscal 2014 Financial Results On Thursday, September 25th, At 4:30 P.M. EST
9/22/2014
-
Transition Therapeutics Inc. To Present At The 16th Annual Rodman & Renshaw Global Investment Conference
9/5/2014
-
Transition Therapeutics Inc. Appoints Carl Damiani As Chief Operating Officer
7/11/2014
-
Transition Therapeutics Inc. Announces Closing Of Private Placement Equity Financing
6/23/2014
-
Transition Therapeutics Inc. Enters Into Deal With Investors To Receive Up To $30.8 Million
6/6/2014
-
Transition Therapeutics Inc. To Host Investor Day And Webcast On May 28th In New York City
5/27/2014
-
Transition Therapeutics Inc. Diabetes Drug Candidate, TT-401, Commences Phase 2 Clinical Study
5/15/2014
-
Transition Therapeutics Inc. Announces Third Quarter Fiscal 2014 Financial Results
5/14/2014
-
Transition Therapeutics Inc. To Hold Conference Call On Third Quarter Fiscal 2014 Financial Results On Tuesday, May 13th, At 4:30 P.M. EST
5/12/2014
-
LifeSci Advisors Initiates Coverage Of Transition Therapeutics Inc.
5/9/2014
-
Transition Therapeutics Inc. Announces Development Update
4/7/2014
-
Transition Therapeutics Inc. Announces Second Quarter Fiscal 2014 Financial Results
2/13/2014
-
Transition Therapeutics Inc. To Present At The 16th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/6/2014
-
Transition Therapeutics Inc. Announces ELND005 Presentations At The Clinical Trials In Alzheimer's Disease (Ctad) Meeting
11/18/2013
-
Transition Therapeutics Inc. Announces First Quarter Fiscal 2014 Financial Results
11/13/2013